These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31824849)

  • 21. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
    Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
    [No Abstract]   [Full Text] [Related]  

  • 22. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients' survival.
    Liu F; Wu X
    J Gastrointest Oncol; 2023 Apr; 14(2):650-662. PubMed ID: 37201038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer.
    Wang K; Zhao B; Liang Y; Ma B
    J Cancer; 2022; 13(1):21-33. PubMed ID: 34976168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
    Chen ZH; Lin YL; Chen SQ; Yang XY
    World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
    Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
    J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated bioinformatics analysis revealing independent prognostic long non-coding RNAs DNAH17-AS1 and RP11-400N13.2 and their potential oncogenic roles in colorectal cancer.
    Zhou W; Pan B; Liu L
    Oncol Lett; 2019 Oct; 18(4):3705-3715. PubMed ID: 31516583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma.
    Jiang S; Xie X; Jiang H
    Transl Cancer Res; 2022 Feb; 11(2):367-381. PubMed ID: 35281422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer.
    Huang R; Zhou L; Chi Y; Wu H; Shi L
    Biomark Res; 2020; 8():8. PubMed ID: 32128213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
    Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY
    Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma.
    Wang S; Chai K; Chen J
    Oncol Lett; 2019 Dec; 18(6):6605-6613. PubMed ID: 31788117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
    Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.
    Zhou C; Wang S; Zhou Q; Zhao J; Xia X; Chen W; Zheng Y; Xue M; Yang F; Fu D; Yin Y; Atyah M; Qin L; Zhao Y; Bruns C; Jia H; Ren N; Dong Q
    Front Oncol; 2019; 9():1160. PubMed ID: 31781487
    [No Abstract]   [Full Text] [Related]  

  • 40. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.